Educational information, not medical advice — ask your doctor or midwife.
Track Keigairengyoto with reminders and record whether it helped, in the app.
Keigairengyoto is a complex, 17-herb Kampo formula that has been used in Japan for centuries to address chronic inflammatory conditions — particularly those affecting the head, face, and upper respiratory tract. It is one of the more widely prescribed Kampo formulas in modern Japanese clinical practice, available as standardized extract granules from manufacturers like Tsumura. The formula blends heat-clearing, blood-moving, and detoxifying herbs into a balanced preparation tailored to a specific constitutional pattern.
The formula works through several overlapping actions: its heat-clearing herbs (Forsythia, Gardenia, Phellodendron) help calm inflammatory signaling; blood-moving herbs (Angelica, Cnidium, Peony) improve circulation and reduce tissue congestion; and herbs like Platycodon and Schizonepeta help open and drain the upper respiratory passages. Together, they address the root cause of recurring inflammation rather than just suppressing symptoms.
In Japan, Keigairengyoto is most commonly dispensed as standardized hot-water extract granules (e.g., Tsumura TJ-50), which are dissolved in warm water and taken before meals. Traditional boiled decoctions are also used by Kampo practitioners who prefer custom dosing. Capsule or tablet forms are less common but available in some markets.
Keigairengyoto traces its origins to classical Chinese herbal medicine texts and was adopted into the Japanese Kampo tradition, where it has been refined and standardized over several centuries. It is particularly well established in Japanese otolaryngology (ENT) and dermatology practice, where it is frequently prescribed alongside or instead of antibiotics for chronic sinus disease and recurrent skin infections.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.